Stockscreener 앱 받기
0.9998
1.01%
-0.0102
시간 외 거래:
.93
-0.0698
-6.98%
전일 마감가:
$1.01
열려 있는:
$0.9797
하루 거래량:
48,926
Relative Volume:
0.22
시가총액:
$2.53M
수익:
$482.00K
순이익/손실:
$-7.51M
주가수익비율:
-0.1072
EPS:
-9.327
순현금흐름:
$-6.63M
1주 성능:
+1.11%
1개월 성능:
+23.43%
6개월 성능:
-66.34%
1년 성능:
-69.24%
1일 변동 폭
$0.914
$1.01
1주일 범위
$0.8226
$1.01
52주 변동 폭
$0.7217
$13.23
티빅 헬스 시스템스 Stock (TIVC) Company Profile
명칭
Tivic Health Systems Inc
전화
(888)276-6888
주소
1305 E. HOUSTON STREET, SAN ANTONIO
Compare TIVC vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
0.9998 | 2.53M | 482.00K | -7.51M | -6.63M | -9.327 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
티빅 헬스 시스템스 주식(TIVC)의 최신 뉴스
Valuation Update: How sensitive is Tivic Health Systems Inc to inflationRecession Risk & Real-Time Volume Triggers - baoquankhu1.vn
Tivic Health outlines $20B oncology market opportunity following strategic transformation - MSN
The Ministry of Health is interested in a new, still poorly researched drug against radiation damage. The agency sent a request to the developerthe American biotech company Tivic Health Systems. Here's what we learned - Dev.ua
Tivic Health Systems Touts Entolimod Phase 3 ARS Path, Eyes BLA in 2027-2028 at Conference - Defense World
Tivic Health Systems Stock (TIVC) Opinions on Emerging Growth Conference Presentation - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market SessionBullfrog AI Hldgs (NASDAQ:BFRG), CDT Eq - Benzinga
TIVC | Tivic Health Systems, Inc. FinancialsIncome Statement - Quiver Quantitative
Valauri buys Tivic Health (TIVC) shares worth $18,008 By Investing.com - Investing.com South Africa
Valauri buys Tivic Health (TIVC) shares worth $18,008 - Investing.com
Tivic Health (TIVC) director adds 19,000 shares in open-market buy - Stock Titan
TIVC Stock Price, Quote & Chart | TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) - ChartMill
TIVC: Entolimod advances toward BLA submission for ARS, with strong clinical and government interest - TradingView
TIVC: Entolimod nears BLA submission for ARS, targeting major oncology and radiation markets - TradingView
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment By Investing.com - Investing.com South Africa
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment - Investing.com
Ukraine weighs Tivic radiation drug for emergency reserves - Stock Titan
Tivic Health Systems Q4 2025 Earnings Call Transcript - MarketBeat
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call Transcript - MSN
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Tivic Health (NASDAQ: TIVC) bets on Entolimod and CDMO build-out despite losses - Stock Titan
Tivic CEO to present at the Upcoming Emerging Growth's April 2026 Virtual Conference - marketscreener.com
Tivic CEO To Present at Emerging Growth Virtual Conference - National Today
New Tivic CEO to spotlight NIAID radiation study deal online - stocktitan.net
Tivic Health secures NIH funding for radiation syndrome study By Investing.com - Investing.com South Africa
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - National Today
Tivic Health secures NIH funding for radiation syndrome study - Investing.com
U.S.-funded Tivic study targets deadly gut damage after radiation - Stock Titan
Tivic Health Systems, Inc. Relocates Headquarters to San Antonio, Texas and Discontinues ClearUP Operations - Minichart
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 By Investing.com - Investing.com South Africa
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 - Investing.com India
TIVC: Transformed into an immunotherapy-focused company with expanded manufacturing and strong cash reserves - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Transcript : Tivic Health Systems, Inc., 2025 Pre Recorded Earnings Call, Mar 25, 2026 - MarketScreener
Tivic Health Unveils 2025 Results and Strategic Pivot - TipRanks
Tivic Health (Nasdaq: TIVC) pivots to Entolimod immunotherapy and CDMO model - stocktitan.net
TIVC: Shifted to immunotherapy, expanded pipeline, and improved cash position despite higher losses - TradingView
Tivic Reports Full Year 2025 Results - ACCESS Newswire
Tivic shuts consumer business, builds immunotherapy and CDMO arms - Stock Titan
Biotech Company Tivic Health Aims to Advance Immunotherapy Research Programs - USA Today
How do insiders feel about Tivic Health Systems IncWeekly Trade Review & Risk Controlled Swing Alerts - baoquankhu1.vn
Tivic Health CEO Letter to Shareholders - Bitget
티빅 헬스 시스템스 (TIVC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):